Austria - Healthcare, Regulatory and Reimbursement Landscape

The publisher, the industry analysis specialist, has released its latest report, “Austria - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The Austrian healthcare system ranks ninth in the world, driven by new emerging technologies for diagnostic procedures, personalized medical treatment, and healthcare IT. The rapidly aging population, unhealthy lifestyle, and advancement in pharmaceutical technology, are the main factors driving the growth of the pharmaceutical market in Austria. The Austrian pharmaceutical market, based on pharmaceutical production value, increased from €2.61B in 2012 to €3.31B in 2019 at a Compound Annual Growth Rate (CAGR) of 3.45%. In terms of US Dollars, the market increased from $3.36B in 2012 to $3.71B in 2019 at a CAGR of 1.43%. It is forecast to reach about $4.04B in 2025. Austria’s medical devices market was valued at $1.69B in 2015, which increased to $2.03B in 2020 at a CAGR of 3.80%. The medical device market is expected to grow at a CAGR of 1.54% from 2021 to $2.33B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Gerot Lannach, Novartis, Pfizer, and Roche
Profiles and SWOT analyses of the major players in the medical device market: Boston Scientific, Getinge, Medtronic, Sanochemia Pharmazeutika, and Smith & Nephew
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the Austria healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving Austrian healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Austrian healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

1.1 List of Figures1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights - Facts about the Austrian Healthcare Market
2.3 Key Highlights: Healthcare Startups in Austria
2.4 Key Events: Austria Healthcare Timeline, 2015-2021
2.5 Key Events: Austria Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Austria, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Austria
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Austria
3.7 COVID-19 Epidemiology, Austria
3.8 COVID-19 Impact and Developments in the Healthcare Market, Austria
3.9 COVID-19 Clinical Trials Landscape, Austria
3.10 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Austria, 2020-2021
6.2 Deal Analysis: Medical Device Market, Austria, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Austria
7.2 Adoption of Technology in Healthcare, Austria
7.3 HealthTech Deals Landscape, Austria
7.4 Key HealthTech Deals, Austria
7.5 Digital Health Regulations, Austria
7.7 COVID-19 Impact on Digital Health, Austria
7.8 HealthTech Landscape: Benefits and Risks, Austria

8. Market Access

8.1 Overview of Healthcare System, Austria
8.2 Reimbursement of Medicinal Products, Austria
8.3 Overview of Insurance Providers, Public Insurance, Austria
8.4 Overview of Insurance Providers, Private Insurance, Austria
8.5 Healthcare Spending and Prescription Drug Price Trend, Austria
8.6 Pricing Policies, Austria
8.7 Regulatory Landscape, Austria
8.7.1 Marketing Authorization for Pharmaceutical Products, EU
8.7.2 Market Authorization for Pharmaceutical Products (Centralized Procedure), Austria
8.7.3 Market Authorization for Pharmaceutical Products (Decentralized Procedure), Austria
8.7.4 Market Authorization for Pharmaceutical Products (Mutual Recognition Procedure), Austria
8.7.5 Marketing Authorization for Pharmaceutical Products (National Procedure), Austria
8.7.6 Marketing Authorization for Medical Devices, Austria
8.7.7 Intellectual Property Rights, European Patent, Austria
8.7.8 Intellectual Property Rights, Unitary Patent, Austria
8.7.9 Intellectual Property Rights, Patent, Austria
8.7.10 Intellectual Property Rights, Trademark, Austria
8.7.11 Clinical Trial Regulation, Austria
8.7.12 Pharmaceutical Clinical Trials Landscape, Austria
8.7.13 Medical Devices Clinical Trials Landscape, Austria
8.7.14 Pharmaceutical Export and Import, Austria
8.7.15 Pharmaceutical Advertising Regulations, Austria
8.7.16 Pharmacy Regulations, Austria
8.7.17 Labeling and Packaging Regulations, Austria

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Austria
9.2 Healthcare Facilities, Austria
9.3 Healthcare Parameters, Austria
9.4 Life Expectancy and Immunization Rate, Austria
9.5 Environmental Health, Austria
9.6 Healthcare Personnel, Austria
9.7 Disease Burden, Austria
9.8 Healthcare Expenditure, Austria
9.9 Healthcare Spending Components and Pharmaceutical Spending, Austria

10 Trade Associations, Austria11 Trade Fairs, Austria12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About The Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables

Table 1: Major Therapeutic Areas by Production Value ($M), Austria, 2019
Table 2: COVID-19 Indicators (Number of Cases), Global and Austria, 2020-2021
Table 3: COVID-19-Related Travel Restrictions, Austria, 2020-2021
Table 4: Approved Medical Devices for COVID-19, Austria, 2020-2021
Table 5: COVID-19 IVD Products, Austria, 2020-2021
Table 6: Medical Device Market, Austria, Major Segments ($B), 2020
Table 7: Hospital Supplies Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 8: General Surgery Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 9: Orthopedic Devices Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Cardiovascular Devices Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: Wound Care Management Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Digitization milestones, Austria, 2020
Table 13: Comparison between Private and Public Health Insurance, Austria, 2021
Table 14: Pharmacy Mark-Up Scheme for Privileged Customers, Austria, 2019
Table 15: Pharmacy Mark-Up Scheme for Private Customers, Austria, 2019
Table 16: Market Authorization Fees, Austria, 2021
Table 17: European Patent Fees, EU, 2021
Table 18: Fees for PRIO Registration, Austria, 2021
Table 19: Austrian Patent Annuities, Austria, 2021
Table 20: Fees for National Patent, Austria, 2021
Table 21: Difference between Patent and Utility Model, Austria, 2021
Table 22: Trademark Fees, Austria, 2021
Table 23: Fees of Clinical Trials with Medicinal Products, Austria, 2021
Table 24: Fees of Clinical Trials of Medical Devices, Austria, 2021
Table 25: Criteria for Establishing a New Pharmacy, Austria, 2020-2021

List of Figures

Figure 1: Pharmaceutical Market, Austria, Revenue ($B and €B), 2012-2019
Figure 2: Medical Devices Market, Austria, Revenue ($B and €B), 2015-2020
Figure 3: Healthcare Startups in Austria, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Value
Figure 6: Country Profile, Austria, 2020
Figure 7: Pharmaceutical Market, Austria, Revenue ($B and €B), 2012-2019
Figure 8: Pharmaceutical Market, Austria, Revenue Forecast ($B and €B), 2020-2025
Figure 9: Pharmaceutical Exports ($B), Austria, 2013-2020
Figure 10: Top Export Partners, Austria, 2020
Figure 11: Pharmaceutical Imports ($B), Austria, 2013-2020
Figure 12: Top Import Partners, Austria, 2020
Figure 13: Pharmaceutical Supply Channel , Austria, 2020
Figure 14: Working of ELGA, Austria, 2021
Figure 15: Generic Share by Volume (%), Austria, 2013-2019
Figure 16: Generic Share by Value (%), Austria, 2013-2019
Figure 17: OTC Medicines Market, Major Distribution Channels ($M), Austria, 2020
Figure 18: OTC Medicines Market, Revenue ($B), Austria, 2013-2020
Figure 19: OTC Medicines Market, Major Categories ($M), Austria, 2020
Figure 20: Major Therapeutic Areas by Production Value (%), Austria, 2019
Figure 21: COVID-19 Cases, Austria, 2020-2021
Figure 22: COVID-19 Deaths, Austria, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, Austria, 2020-2021
Figure 24: COVID-19 Vaccination Progress, Austria, 2021
Figure 25: COVID-19 Vaccination Plan, Austria, 2021
Figure 26: COVID-19 Approved Vaccines, Austria, 2021
Figure 27: 3G Rule Evidences, Austria, 2021
Figure 28: COVID-19 Clinical Trials Count by Trial Status, Austria, 2020-2021
Figure 29: COVID-19 Top Market Categories by Clinical Trials, Austria, 2020-2021
Figure 30: Top Six COVID-19 Clinical Trials Sponsors by Trial Count, Austria, 2020-2021
Figure 31: Medical Devices Market, Austria, Revenue ($B), 2015-2020
Figure 32: Medical Devices Market, Austria, Revenue Forecast ($B), 2021-2025
Figure 33: Medical Device Market, Austria, Major Segments (%), 2020
Figure 34: Hospital Supplies Market, Austria, Revenue ($B), 2017-2025
Figure 35: Hospital Supplies Market, Austria, Market Share of Major Players (%), 2020
Figure 36: General Surgery Market, Austria, Revenue ($M), 2017-2025
Figure 37: General Surgery Market, Austria, Market Share of Major Players (%), 2020
Figure 38: Orthopedic Devices Market, Austria, Revenue ($M), 2017-2025
Figure 39: Orthopedic Devices Market, Austria, Market Share of Major Players (%), 2020
Figure 40: Cardiovascular Devices Market, Austria, Revenue ($M), 2017-2025
Figure 41: Cardiovascular Devices Market, Austria, Market Share of Major Players (%), 2020
Figure 42: Wound Care Management Market, Austria, Revenue ($M), 2017-2025
Figure 43: Wound Care Management Market, Austria, Market Share of Major Players (%), 2020
Figure 44: Diagnostics Market, Austria, Revenue ($M), 2015-2020
Figure 45: Diagnostics Market, Austria, Revenue Forecast ($M), 2021-2025
Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Austria, 2019-2021
Figure 47: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Austria, 2019-2021
Figure 48: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Austria, 2019-2021
Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Austria, 2019-2021
Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Austria, 2019-2021
Figure 51: M&A Deals by Quarter, Pharmaceutical Market, Austria, 2019-2021 (by Value and by Number)
Figure 52: VC Deals by Quarter, Pharmaceutical Market, Austria, 2019-2021 (by Value and by Number)
Figure 53: Deal Value and Deal Count, Medical Devices Market, Austria, 2019-2021
Figure 54: Deal Value and Deal Count Sub-types, Medical Devices Market, Austria, 2019-2021
Figure 55: Deal Value and Deal Count, Quarterly, Medical Devices Market, Austria, 2019-2021
Figure 56: Top Equipment Sectors by Deal Value, Medical Devices Market, Austria, 2019-2021
Figure 57: Top Equipment Sectors by Deal Count, Medical Devices Market, Austria, 2019-2021
Figure 58: M&A Deals by Equipment Sector, Medical Devices Market, Austria, 2019-2021 (by Value and by Number)
Figure 59: VC Deals by Quarter, Medical Devices Market, Austria, 2019-2021 (by Value and by Number)
Figure 60: Deal Value ($M) and Deal Count, HealthTech, Austria, 2020-2021
Figure 61: Deal Value and Deal Count (Number of Deals) by sector, HealthTech, Austria, 2020-2021
Figure 62: Digital RoadMap and 12 Guiding Principles, Austria, 2020
Figure 63: Measures defined by Digital Roadmap in the Field of Health, Austria, 2020
Figure 64: GDPR Compliance Checklist, EU, 2021
Figure 65: Digital Health Areas Affected by COVID-19, Austria, 2021
Figure 66: Key Organizations and People of Healthcare System, Austria, 2021
Figure 67: Organization of Austrian Healthcare System, Austria, 2021
Figure 68: Reimbursement of Medicines, Austria, 2021
Figure 69: Financial Flow, Austria, 2021
Figure 70: Budget of Health Insurance Institutions (%), Austria, 2018
Figure 71: Umbrella Organization, Austria, 2021
Figure 72: OOP Expenditure (% of Total Expenditure on Health), Austria, 2013-2020
Figure 73: Annual Average Rate of Change (%), Health Price Index, Austria, 2012-2020
Figure 74: BASG Organizational Structure, Austria, 2021
Figure 75: Marketing Authorization for Pharmaceutical Products, EU, 2020
Figure 76: Centralized Procedure, EU, 2021
Figure 77: Decentralized Procedure, EU, 2021
Figure 78: Mutual Recognition Procedure, EU, 2021
Figure 79: Conformity Assessment of Class I Medical Devices, EU, 2019
Figure 80: Conformity Assessment of Class IIa Medical Devices, EU, 2019
Figure 81: Conformity Assessment of Class IIb Medical Devices, EU, 2019
Figure 82: Conformity Assessment of Class III Medical Devices, EU, 2019
Figure 83: European Patent Approval Process, EU, 2020

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1982EUR$1,995USD£1,648GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3964EUR$3,990USD£3,296GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5946EUR$5,985USD£4,944GBP

Scope

Reasons to Buy

Table of Contents

Related Topics

Related Reports

Medical Case Management Service Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

Revenue Cycle Management System Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, and Product Type

2024 Global Forecast for Healthcare Payer Services Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

2024 Global Forecast for Medical Billing Outsourcing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

2024 Group Managed Care Medical Service Plans Underwriting Services Global Market Size & Growth Report with Updated Recession Risk Impact